药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chlormezanone
Milnacipran
The risk or severity of adverse effects can be increased when Gaboxadol is combined with Milnacipran.
Chlormezanone
Dapoxetine
The risk or severity of adverse effects can be increased when Gaboxadol is combined with Dapoxetine.
Chlormezanone
Tetracosactide
The risk or severity of liver damage can be increased when Tetracosactide is combined with Gaboxadol.
Chlormezanone
Mianserin
The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Mianserin.
Chlormezanone
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gaboxadol.
Chlormezanone
Suvorexant
Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Chlormezanone
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Gaboxadol.
Chlormezanone
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Gaboxadol.
Chlormezanone
Rotigotine
Gaboxadol may increase the sedative activities of Rotigotine.
Chlormezanone
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gaboxadol.
Chlormezanone
Paraldehyde
Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Chlormezanone
Methotrimeprazine
Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Cyclizine
Satralizumab
The serum concentration of Prucalopride can be decreased when it is combined with Satralizumab.
Cyclizine
Abametapir
The serum concentration of Prucalopride can be increased when it is combined with Abametapir.
Cyclizine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Prucalopride.
Cyclizine
Cenobamate
The serum concentration of Prucalopride can be decreased when it is combined with Cenobamate.
Cyclizine
Sulfate ion
The risk or severity of adverse effects can be increased when Prucalopride is combined with Sulfate ion.
Cyclizine
Sodium cation
The risk or severity of adverse effects can be increased when Prucalopride is combined with Sodium cation.
Cyclizine
Glycerin
The risk or severity of adverse effects can be increased when Prucalopride is combined with Glycerin.
Cyclizine
Polyethylene glycol
The risk or severity of adverse effects can be increased when Prucalopride is combined with Polyethylene glycol.